Citi Pharma Limited (PSX:CPHL)

Citi Pharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 22, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	20,445	19,184	6,511	4,875	7,457	-
Market Cap Growth	136.87%	194.63%	33.55%	-34.62%	-	-
Enterprise Value	21,805	20,807	6,236	4,443	5,627	-
Last Close Price	89.49	80.81	25.42	17.15	26.24	-
PE Ratio	22.95	21.51	7.81	7.41	11.41	-
PS Ratio	1.55	1.46	0.53	0.39	0.76	-
PB Ratio	1.88	1.77	1.16	0.91	1.58	-
P/TBV Ratio	1.88	1.77	1.16	0.91	1.58	-
P/FCF Ratio	-	-	8.46	-	-	-
P/OCF Ratio	-	-	4.87	-	-	-
EV/Sales Ratio	1.66	1.58	0.50	0.36	0.57	-
EV/EBITDA Ratio	12.30	11.78	4.64	3.53	5.28	-
EV/EBIT Ratio	13.59	12.97	5.17	3.81	5.66	-
EV/FCF Ratio	-46.32	-	8.11	-	-	-
Debt / Equity Ratio	0.27	0.27	0.26	0.34	0.20	0.07
Debt / EBITDA Ratio	1.66	1.66	1.08	1.46	0.88	0.50
Debt / FCF Ratio	-	-	1.89	-	-	-
Asset Turnover	0.88	0.88	1.16	1.37	1.34	1.29
Inventory Turnover	3.12	3.12	3.72	5.06	6.82	6.02
Quick Ratio	0.66	0.66	0.68	0.80	1.15	1.92
Current Ratio	1.30	1.30	1.36	1.48	1.86	2.45
Return on Equity (ROE)	10.81%	10.81%	15.14%	13.05%	14.40%	13.16%
Return on Assets (ROA)	6.71%	6.71%	7.03%	8.06%	8.49%	7.96%
Return on Capital (ROIC)	9.59%	9.59%	10.54%	11.34%	12.01%	11.62%
Return on Capital Employed (ROCE)	14.40%	14.40%	20.60%	21.10%	19.40%	12.20%
Earnings Yield	4.36%	4.65%	12.80%	13.50%	8.77%	-
FCF Yield	-2.30%	-2.45%	11.82%	-26.33%	-12.38%	-
Dividend Yield	3.91%	4.33%	12.78%	14.57%	-	-
Payout Ratio	82.94%	82.94%	68.53%	-	47.66%	-
Buyback Yield / Dilution	-	-	-	-0.70%	-21.65%	-88.38%
Total Shareholder Return	3.80%	4.33%	12.78%	13.87%	-21.65%	-88.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.